NSAIDs and GI and Renal Complications Lessons from Tennessee Medicaid population studies (and selected others)

Slides:



Advertisements
Similar presentations
Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
Advertisements

Update in Prescribing and therapeutics: NSAID’s in Emergency Medicine.
Literature Review Peter R. McNally, DO, FACP, FACG University Colorado Denver School of Medicine Center for Human Simulation Aurora, Colorado
Lynda K. Ball, MSN, RN, CNN Quality Improvement Director Northwest Renal Network Improving Sub-Optimal Hemoglobins October 14, 2010.
Overview of Aspirin and NSAID’s Label Warnings William E. Gilbertson, PharmD. Division OTC Drug Products 1.
Department of Health and Human Services Center for Drug Evaluation and Research Review of Epidemiologic Studies on Cardiovascular Risk with Selected NSAIDs.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen.
Walsall Healthcare NHS Trust Medicines Management.
Australasian Society of Clinical Immunology and Allergy Adverse Reactions to NSAIDs David Henry Faculty of Medicine and Health Sciences The University.
Presentations in this series 1.Introduction 2.Self-matching 3.Proxies 4.Intermediates 5.Instruments 6.Equipoise Avoiding Bias Due to Unmeasured Covariates.
ICS in COPD – A Risk Factor for CAP? Rate of pneumonia in ICS Studies
Primary care of hypertensive patients and the risk of acute events Irina Stirbu-Wagner Markus MJ Nielen Maaike Langelaan Robert A. Verheij Joke C. Korevaar.
1 Bayer Corporation Consumer Care Division September 20, 2002 Allen H. Heller, MD Vice President, Global Research & Development Consumer Care NDAC Hearing.
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
BS Evidence Based Medicine And Atrial Fibrillation.
Hospitalizations for Severe Sepsis Among Elderly Medicare Beneficiaries William Buczko, Ph.D. Research Analyst Centers for Medicare & Medicaid Services.
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
How to reduce hospital admissions due to high risk drugs Dr Martin Duerden 1.
An Update on NSAID Labeling and Data Review DSaRM Advisory Committee February 10, 2006 Sharon Hertz, M.D. Deputy Director Division of Anesthesia, Analgesia,
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.
FDA:ODE I:DCRDP:JCP:9/20/02:OTC NSAIDs: 1 OTC NSAIDs AND NEPHROTOXICITY Juan Carlos Pelayo, M.D. On Behalf Of The Division Of Cardio-Renal Drug Products.
Risk of colorectal cancer in patients taking statins and NSAIDS Dr Yana Vinogradova, Prof Julia Hippisley-Cox, Dr Carol Coupland and Prof Richard Logan.
An epidemiologic perspective on etoricoxib David J. Graham, MD, MPH Office of Surveillance and Epidemiology April 12, 2007.
Gastrointestinal Review Highlights of the VIGOR Trial Lawrence Goldkind M.D.
OTC NSAIDs AND NEPHROTOXICITY Juan Carlos Pelayo, M. D
CRITICAL APPRAISAL OF ARTICLE ON HARM. Among patients with acute rheumatic fever, will administration of non steroidal anti- inflammatory drugs have adverse.
Update of TARGET ( T reatment a nd R elief of G astroint e s t inal disorder) DR NORITA YASMIN MORNING READ 19/9/13 1.
Ibuprofen and Renal Failure Professor Nicholas Moore International Ibuprofen Foundation University of Bordeaux, France.
COMET: Carvedilol Or Metoprolol European Trial Purpose To compare the effects of carvedilol (a β 1 -, β 2 - and α 1 -receptor blocker) and short-acting.
NDAs /772 Etoricoxib Robert B. Shibuya, M.D. Medical Officer Division of Anesthesia, Analgesia, and Rheumatology Products.
ELITE - II Study Design  60 yrs; NYHA II - IV; EF  40 % ACEI naive or  7 days in 3 months prior to entry Standard Rx ( ± Dig / Diuretics ), ß - blocker.
OTC NSAID and ASA GI Bleeding Analysis of Spontaneous Reports Nonprescription Drugs Advisory Committee Meeting Joyce P. Weaver, Pharm.D. Office of Drug.
Self-Controlled Studies Case Crossover Case Series
Small Bowel Toxicity of Nonselective NSAIDs Revealed by Capsule Endoscopy: Results From a Pivotal Clinical Trial Glenn M. Eisen, M.D., M.P.H. Associate.
Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients Gradman AH, Parisé H, Lefebvre P, Falvey H, Lafeuille MH,
Hot Topic Presentation Lars Halford, GP ST3 March 2010
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
Journal Club Mallory McClester, PGY-4 August 16, 2013.
 In 2014, NSAIDs were prescribed more than 100 million times per year in USA.  29 million adults (12.1%) were regular NSAIDs user in USA. 2.
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Risk of Bleeding With Dabigatran in Atrial Fibrillation.
NHS Specialist Pharmacy Service Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Service Medicines Use & Safety.
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
Care Home Medicine Dr Rhian Simpson Consultant Community Geriatrician Cambridgeshire Community Services.
Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users C. Sostres, MD, P. Carrera-Lasfuentes, PhD, R. Benito,
Joseph J.Y. Sung, MD et al. Am J Gastroenterol 2010;105. R3 김민경.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates.
Malnutrition is common in US hospitalized patients In 2010, approximately 1.2 million hospitalized patients over the age of 18 had.
Ventilator-associated Pneumonia Among Elderly Medicare Beneficiaries in Long-term Care Hospitals William Buczko, Ph.D. Research Analyst Centers for Medicare.
Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study 소화기 내과 R1 박지윤 Ofke S.
Acute Renal Failure in Aneurysmal Subarachnoid Hemorrhage: Nationwide Analysis of Hospitalizations in the United States Kavelin Rumalla 1, Adithi Y. Reddy.
NHS Specialist Pharmacy Service NSAIDS – efficacy and safety Expert speaker Slide set Key content from the NPC NSAIDS QIPP slides is gratefully acknowledged.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Opiate use in patients with inflammatory bowel disease
Health and Human Services National Heart, Lung, and Blood Institute
NYHA III* or IV heart failure ACE-I + loop diuretic ± digoxn
Selection of NSAIDs for Osteoarthritis
NSAIDs: Risk of acute MI compared with remote use
Creatinine clearance (mL/min) n All-cause mortality (%)
Risk of Upper Gastrointestinal Complications Among Users of Traditional NSAIDs and COXIBs in the General Population  Luis A. García Rodríguez, Laura Barreales.
Volume 151, Issue 6, Pages e10 (December 2016)
Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors
Nonsteroidal anti-inflammatory drug gastropathy
Volume 133, Issue 3, Pages (September 2007)
Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.
Risk of mortality in patients with diabetes and ESRD
Presentation transcript:

NSAIDs and GI and Renal Complications Lessons from Tennessee Medicaid population studies (and selected others)

Overview Upper GI complications of NSAIDs –Age –Dose/duration –Corticosteroids –Coumadin Renal complications Other

Age-specific peptic ulcer hospitalization rates by sex and NSAID use, Saskatchewan, Female nonusers Male nonusers Female users Male users Age Hospitalizations per 1,000 person-years Garcia Rodriguez et al, Epidemiology 1992

Hospitalizations for PUD Tennessee Medicaid, age 65+, Griffin et al Ann Intern Med 1991

Gastrointestinal Complications meta-analysis: 5 studies that included dose Henry et al Br Med J 1996

Hospitalizations for PUD Tennessee Medicaid, age 65+, Smalley et al Am J Epidemiol 1995

Hospitalizations for PUD Tennessee Medicaid, age 65+, Smalley et al Am J Epidemiol 1995

Corticosteroids and NSAIDs Co-prescription 1-3% of elderly –Similar to non-NSAID users Increases risk fold over non-users Ulcer hospitalization: 5-6 per 100 per year

Coumadin and NSAIDs Co-prescription 1-2% of elderly –Similar to non-NSAID users Increases risk of GI bleeding 12 fold over non-users Ulcer hospitalization: 3 per 100 per year

NSAIDs and Acute Renal Failure, Tennessee Medicaid, aged 65+, patients community acquired ARF –4.5 hospitalization per 1000 person-years –Median length of stay 8 days –3% dialysis –30 day mortality 36%

NSAIDs and other risk factors for ARF 18% NSAID users –Adjusted RR 1.58 Other risk factors –Older age –Male gender –Black race –Nusing home resident –Diuretics –ACE inhibitors –Other co-morbidity

Individual NSAIDs NSAIDRR 95% CI Ibuprofen 1.63 (1.23 to 2.08) Naproxen 1.03(0.68 to 1.56) Ketoprofen1.55 (0.54 to 4.45)

Ibuprofen dose and ARF Tennessee Medicaid, age 65+, Griffin et al Am J Epidemiol 2000

Duration of NSAID use and ARF Tennessee Medicaid, age 65+, Griffin et al Am J Epidemiol 2000

Other Considerations: Upper GI and renal effect OTC drugs may be self-administered as previously “prescribed” (high dose) OTC drugs may be used for long duration Risk increases with combination of >1 NSAID For GI events risk increases with aspirin use

Other Considerations: Important other adverse effects Hypertension –Small increases in mean BP, large population effect Small bowel and lower GI bleeding Dyspepsia –Increased health care costs Other